Validation of microdialysis sampling for subcutaneous extracellular valproic acid in humans.
This article is the second in a series of studies aimed at monitoring valproic acid pharmacokinetics in patients with epilepsy by subcutaneous microdialysis. In the current study, a detailed investigation on healthy volunteers is made of the relationship between total concentrations in plasma, free concentrations in plasma, and dialysate concentrations. Particular emphasis is put on validating that the in vivo recovery under standard conditions (30 mm dialyzing membrane and 0.5 microl/minute perfusion rate) is sufficiently close to 100%. It was found that the recovery was very close to 100% at 0.5 microl/minute and by in vitro studies it could be excluded that valproic acid binds to the dialysis equipment. The correlation between unbound plasma concentrations and microdialysis concentrations of valproic acid was acceptable (r = 0.80), and they did not differ systematically from one another. It is concluded that microdialysis can be used to sample subcutaneous extracellular valproic acid in a clinical setting giving reliable estimates of the unbound concentration in plasma.
Lindberger
M
M
Department of Clinical Pharmacology, Karolinska Institute, Huddinge Hospital, Sweden.
Tomson
T
T
Ståhle
L
L
D000927:Anticonvulsants / Q000097:blood*; D002849:Chromatography, Gas; D016903:Drug Monitoring / Q000379:methods*; D006801:Humans; D017551:Microdialysis / Q000379:methods*; D012016:Reference Values; D012680:Sensitivity and Specificity; D013997:Time Factors; D014635:Valproic Acid / Q000097:blood*
D000927:Anticonvulsants; D014635:Valproic Acid